Sustained Pericarditis Recurrence Risk Reduction With Long‐Term Rilonacept [PDF]
Background Rilonacept, a once‐weekly interleukin‐1 alpha and beta cytokine trap, reduced pericarditis recurrence in the phase 3 study, RHAPSODY (Rilonacept Inhibition of Interleukin‐1 Alpha and Beta for Recurrent Pericarditis: A Pivotal Symptomatology ...
Basil S Lewis +2 more
exaly +7 more sources
A Comprehensive Clinical Evaluation of Rilonacept in the Treatment of Recurrent Pericarditis: A Systematic Review [PDF]
Yue Yu, Jiajing Chen, Zhao Zhao, Moting Qian, Yufei Zhang, Chunlai Ma Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, 200040, People’s Republic of ChinaCorrespondence: Chunlai Ma, Email chunlaima@126.comObjective: Recurrent ...
Yu Y +5 more
exaly +6 more sources
Comprehensive Clinical Analysis of Rilonacept in the Treatment of Cryopyrin-Associated Periodic Syndromes: A Systematic Review [PDF]
Tian Zhang,1 Yue Yu,2 Jiajing Chen,2 Zhao Zhao,2 Moting Qian,2 Yufei Zhang,2 Chunlai Ma,2 Feng Chang3 1Institute of Science and Technology, China Pharmaceutical University, Nanjing, 211198, People’s Republic of China; 2Department of Pharmacy, Huashan ...
Zhang T +7 more
exaly +6 more sources
Inhibition of Interleukin-1 With Rilonacept Is Not Effective in Cold Urticaria—Results of a Randomized, Placebo-Controlled Study [PDF]
Background Cold urticaria (ColdU) is characterized by pruritic wheals following exposure of the skin to cold. Many patients show insufficient response to antihistamines, the first line treatment.
Karoline Krause +2 more
exaly +4 more sources
Interleukin‐1 Trap Rilonacept Improved Health‐Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY [PDF]
Background Recurrent pericarditis is characterized by painful flares and inflammation, which negatively impact health‐related quality of life. RHAPSODY (rilonacept inhibition of interleukin‐1 alpha and beta for recurrent pericarditis: a pivotal ...
Michelle Z Lim-Watson +2 more
exaly +4 more sources
Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy [PDF]
Panayotis K Vlachakis, Panagiotis Theofilis, Stergios Soulaidopoulos, Emilia Lazarou, Konstantinos Tsioufis, George Lazaros First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens ...
Panagiotis Theofilis +2 more
exaly +5 more sources
Autoinflammatory diseases (AIDs) represent a rare and heterogeneous group of disorders characterized by recurrent episodes of inflammation and a broad range of clinical manifestations.
Hana Malcova +8 more
doaj +1 more source
Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent Pericarditis
Acute pericarditis is the most frequent pericardial disease characterized by inflammation of the pericardial layers resulting in pain, dyspnea and fatigue.
Aldo Bonaventura +8 more
doaj +1 more source
BackgroundThe cytokine interleukin (IL)-1 plays a pivotal role in immune-mediated disorders, particularly in autoinflammatory diseases. Targeting this cytokine proved to be efficacious in treating numerous IL-1-mediated pathologies. Currently, three IL-1
Dennis D. Arnold +3 more
doaj +1 more source
Background Impact of recurrent pericarditis (RP) on patient health-related quality of life (HRQoL) was evaluated through qualitative patient interviews and as an exploratory endpoint in a Phase 2 trial evaluating the efficacy and safety of rilonacept (IL-
David Lin +13 more
doaj +1 more source

